Developer docs
API playgroundTry for free, no card

Search company profiles

MyChem

Full company profile

uuid000hsct

Namestring
MyChem
Websiteurl
mychemlabs.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

MyChem is a privately held, for-profit specialty manufacturer founded in 2007 and based in San Diego, California. Per its firmographic profile, the company is specialized in making ultra-pure nucleotides — the building blocks of DNA and RNA used across molecular biology, genomics research, diagnostic assay development, and increasingly in therapeutic applications such as mRNA-based medicines and gene therapy. The company operates with a very lean team of 1-10 employees, indicating a boutique, technically focused operation rather than a high-volume commodity chemicals producer.

The company's product category positions it as a supplier into the life sciences research tools and biopharma inputs value chain, where purity specifications are critical and buyers are typically research institutions, diagnostic developers, and pharmaceutical or biotech companies. MyChem's website is hosted at mychemlabs.com, consistent with a laboratory-inputs branding posture.

The available source data is materially incomplete. Multiple collection attempts returned a verification/waiting page on the company website with no substantive product catalog, pricing, customer list, certifications, leadership bios, funding history, or revenue disclosures. As a result, no business model details (direct vs. distributor sales, catalog vs. custom synthesis, pricing tiers), no end-market segmentation, and no operating metrics are verifiable from the provided inputs. Any investment thesis built on MyChem will require primary diligence — direct outreach, sample customer interviews, and review of internal financials — to confirm revenue scale, customer concentration, and competitive positioning within the ultra-pure nucleotides market.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
ultra pure nucleotides, nucleotide manufacturing, biochemical reagents, molecular biology supplies, custom nucleotide synthesis
Industry1 code
PRIMARYIMAEABAD
Electronic & High-Purity Specialty Chemicals
NAICS code1 code
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Industrial Organic Chemicals2860
Product category
Biochemical Reagents
No data
Cost components4 values
Personnel, Supply Chain, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

MyChem manufactures and supplies ultra pure nucleotides for molecular biology, diagnostics, and biotechnology research applications. The company operates a small specialty chemical production operation based in San Diego, California, focused on producing high-purity nucleotide reagents for life sciences customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MyChem offers chemical analysis and laboratory services. The company website displays a verification page with no accessible product content at the time of data collection.

Product and service1 record
1Ultra Pure Nucleotides
No data
Peers10 records
TypeBroad incumbent
Description

Agilent supplies nucleic-acid reagents, oligonucleotides, and genomics consumables alongside its instruments. It overlaps with MyChem in research and diagnostic-grade nucleotide/nucleic-acid chemistry.

TypeDirect peer
Description

TriLink is a leading manufacturer of nucleotides, mRNA building blocks, and clean cap analogs. It directly overlaps with MyChem's ultra-pure nucleotide specialization but operates at much greater scale within nucleic-acid therapeutics supply chains.

TypeDirect peer
Description

Hongene is a specialty manufacturer of nucleosides, nucleotides, and phosphoramidites used in RNA/DNA therapeutics and diagnostics. It is a direct comparable to MyChem in the high-purity nucleotide space.

4Nitto Denko Avecia
TypeDirect peer
Description

Avecia is a CDMO specializing in oligonucleotide and nucleic-acid manufacturing, including production of nucleotide building blocks. It is a direct peer serving therapeutics and diagnostics customers in the same value chain as MyChem.

TypeDirect peer
Description

Glen Research manufactures reagents for oligonucleotide synthesis, including high-purity nucleoside phosphoramidites and related building blocks. It is a direct peer in the ultra-pure nucleotide/nucleoside supply category.

TypeDirect peer
Description

ChemGenes is a specialty manufacturer of nucleosides, nucleotides, phosphoramidites, and oligonucleotides used in DNA/RNA synthesis. It serves essentially the same customer set as MyChem and competes directly on ultra-pure raw materials.

TypeDirect peer
Description

Biosynth supplies specialty chemicals and reagents including nucleosides, nucleotides, and synthesis reagents for genomics and diagnostics. It directly competes in the ultra-pure nucleotide category MyChem serves.

TypeDirect peer
Description

IDT manufactures custom oligonucleotides, nucleotides, and nucleic-acid reagents for research and diagnostics. It is a direct comparable in the high-purity nucleotide/oligonucleotide space and shares San Diego-area roots with MyChem.

TypeBroad incumbent
Description

Thermo Fisher supplies nucleotides, modified nucleotides, and nucleic-acid reagents across research, diagnostics, and therapeutics through its extensive catalog. It is a broad incumbent competing across all of MyChem's potential end-markets.

TypeBroad incumbent
Description

Sigma-Aldrich/Merck is the dominant broad-line supplier of nucleotides, nucleosides, and life-science reagents. It competes with MyChem across the entire nucleotide catalog and sets the price/quality benchmark for the market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MyChem

Biochemical Reagentsmychemlabs.com

What MyChem does

MyChem is a privately held, for-profit specialty manufacturer founded in 2007 and based in San Diego, California. Per its firmographic profile, the company is specialized in making ultra-pure nucleotides — the building blocks of DNA and RNA used across molecular biology, genomics research, diagnostic assay development, and increasingly in therapeutic applications such as mRNA-based medicines and gene therapy. The company operates with a very lean team of 1-10 employees, indicating a boutique, technically focused operation rather than a high-volume commodity chemicals producer.

The company's product category positions it as a supplier into the life sciences research tools and biopharma inputs value chain, where purity specifications are critical and buyers are typically research institutions, diagnostic developers, and pharmaceutical or biotech companies. MyChem's website is hosted at mychemlabs.com, consistent with a laboratory-inputs branding posture.

The available source data is materially incomplete. Multiple collection attempts returned a verification/waiting page on the company website with no substantive product catalog, pricing, customer list, certifications, leadership bios, funding history, or revenue disclosures. As a result, no business model details (direct vs. distributor sales, catalog vs. custom synthesis, pricing tiers), no end-market segmentation, and no operating metrics are verifiable from the provided inputs. Any investment thesis built on MyChem will require primary diligence — direct outreach, sample customer interviews, and review of internal financials — to confirm revenue scale, customer concentration, and competitive positioning within the ultra-pure nucleotides market.

MyChem firmographics

Firmographics
Name
MyChem
Website
https://mychemlabs.com
Company type
Private
Founded year
2007
Headcount range
1–10 employees
Ownership category
akta.pro rank

MyChem industry classification

Industry
Product category
Biochemical Reagents
NAICS
Pharmaceutical and Medicine Manufacturing (3254)
SIC
Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYIMAEABAD
Electronic & High-Purity Specialty Chemicals

Keywords

  • Ultra pure nucleotides
  • Nucleotide manufacturing
  • Biochemical reagents
  • Molecular biology supplies
  • Custom nucleotide synthesis

Where MyChem is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

MyChem business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Infrastructure

MyChem product offering

Product offering

Core offering

MyChem manufactures and supplies ultra pure nucleotides for molecular biology, diagnostics, and biotechnology research applications. The company operates a small specialty chemical production operation based in San Diego, California, focused on producing high-purity nucleotide reagents for life sciences customers.

Product overview

MyChem offers chemical analysis and laboratory services. The company website displays a verification page with no accessible product content at the time of data collection.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ultra Pure Nucleotides

Companies that use MyChem

Customer profile

Ideal customer profiles1 record

MyChem technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MyChem competitors and assessment

Company assessment

Broad incumbents

  • Agilent Technologies: Agilent supplies nucleic-acid reagents, oligonucleotides, and genomics consumables alongside its instruments. It overlaps with MyChem in research and diagnostic-grade nucleotide/nucleic-acid chemistry.
  • Thermo Fisher Scientific: Thermo Fisher supplies nucleotides, modified nucleotides, and nucleic-acid reagents across research, diagnostics, and therapeutics through its extensive catalog. It is a broad incumbent competing across all of MyChem's potential end-markets.
  • Sigma-Aldrich / Merck Life Science: Sigma-Aldrich/Merck is the dominant broad-line supplier of nucleotides, nucleosides, and life-science reagents. It competes with MyChem across the entire nucleotide catalog and sets the price/quality benchmark for the market.

Direct peers

  • TriLink BioTechnologies (Maravai LifeSciences): TriLink is a leading manufacturer of nucleotides, mRNA building blocks, and clean cap analogs. It directly overlaps with MyChem's ultra-pure nucleotide specialization but operates at much greater scale within nucleic-acid therapeutics supply chains.
  • Hongene Biotech: Hongene is a specialty manufacturer of nucleosides, nucleotides, and phosphoramidites used in RNA/DNA therapeutics and diagnostics. It is a direct comparable to MyChem in the high-purity nucleotide space.
  • Nitto Denko Avecia: Avecia is a CDMO specializing in oligonucleotide and nucleic-acid manufacturing, including production of nucleotide building blocks. It is a direct peer serving therapeutics and diagnostics customers in the same value chain as MyChem.
  • Glen Research: Glen Research manufactures reagents for oligonucleotide synthesis, including high-purity nucleoside phosphoramidites and related building blocks. It is a direct peer in the ultra-pure nucleotide/nucleoside supply category.
  • ChemGenes Corporation: ChemGenes is a specialty manufacturer of nucleosides, nucleotides, phosphoramidites, and oligonucleotides used in DNA/RNA synthesis. It serves essentially the same customer set as MyChem and competes directly on ultra-pure raw materials.
  • Biosynth (formerly BioSynth / Glen Research portfolio): Biosynth supplies specialty chemicals and reagents including nucleosides, nucleotides, and synthesis reagents for genomics and diagnostics. It directly competes in the ultra-pure nucleotide category MyChem serves.
  • Integrated DNA Technologies (IDT, Danaher): IDT manufactures custom oligonucleotides, nucleotides, and nucleic-acid reagents for research and diagnostics. It is a direct comparable in the high-purity nucleotide/oligonucleotide space and shares San Diego-area roots with MyChem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

MyChem financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MyChem leadership team

Management profile

Number of profiles

MyChem funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MyChem M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyChem

What does MyChem do?

MyChem manufactures and supplies ultra pure nucleotides for molecular biology, diagnostics, and biotechnology research applications. The company operates a small specialty chemical production operation based in San Diego, California, focused on producing high-purity nucleotide reagents for life sciences customers.

When was MyChem founded?

MyChem was founded in 2007. It employs 1 to 10 people.

Where is MyChem based?

MyChem is headquartered in San Diego, United States, in the North America region.

Who are MyChem's main competitors?

Broad incumbents on record are Agilent Technologies, Thermo Fisher Scientific and Sigma-Aldrich / Merck Life Science. Direct peers are TriLink BioTechnologies (Maravai LifeSciences), Hongene Biotech, Nitto Denko Avecia, Glen Research, ChemGenes Corporation, Biosynth (formerly BioSynth / Glen Research portfolio) and Integrated DNA Technologies (IDT, Danaher).

Does MyChem have an API?

No public API is recorded for MyChem.

What industry is MyChem in?

MyChem's product category is Biochemical Reagents. Its primary akta.pro industry code is IMAEABAD, Electronic & High-Purity Specialty Chemicals. Its NAICS code is 3254 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales